| Nazwa produktu | Dihydronicotinamide Riboside (NRH) |
|---|---|
| Numer CAS | 19132-12-8 |
| Wzór cząsteczkowy | C₁₁H₁₈N₂O₄ |
| Masa cząsteczkowa | 242.27 g/mol |
| Wygląd | White to off-white powder |
| Oznaczenie (HPLC) | ≥ 98,01 TP3T |
| Strata przy suszeniu | ≤ 5.0% |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem
Dihydronicotinamide Riboside (NRH) is a reduced form of nicotinamide riboside (NR) and a novel member of the vitamin B₃ family.
It serves as a highly efficient precursor to NAD⁺ (nicotinamide adenine dinucleotide), the essential coenzyme involved in cellular energy metabolism, DNA repair, and redox signaling.
NRH has gained significant attention in recent years due to its superior efficacy compared to other NAD⁺ precursors, including NR and NMN (nicotinamide mononucleotide).
Studies suggest that NRH can elevate NAD⁺ levels more rapidly and at lower doses, making it a promising candidate for anti‑aging, metabolic health, and mitochondrial support applications.
| Związek | Nr CAS. | Związek |
|---|---|---|
| Dihydronicotinamide Riboside (NRH) | 19132-12-8 | Reduced, highly active NAD⁺ precursor |
| Nicotinamide Riboside (NR) | 1341-23-7 | Oxidized form, NAD⁺ precursor |
| Nicotinamide Mononucleotide (NMN) | 1094-61-7 | NAD⁺ precursor |
| Nicotinamide Adenine Dinucleotide (NAD⁺) | 53-84-9 | Active coenzyme |
Czystość: ≥98,01 TP3T (HPLC)
Miesięczna wydajność: 5+ kg
Czas realizacji: 3–5 dni (próbki), 10–15 dni (towar luzem)
Dokumentacja: COA,HPLC chromatogram, stability data, NMR (upon request)
LyvBio Sp. z o.o.
E-mail: info@lyvbio.com
Strona internetowa: https://www.lyvbio.com
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese